Forward Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3

- Investments
-
100
- Portfolio
-
5
- Exits
-
55

Forward Ventures General Information
Description
Founded in 1990, Forward Ventures is a venture capital firm based in San Diego, California. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, life sciences, oncology, and TMT sectors in the United States.
Contact Information
Website
www.forwardventures.com
Year Founded
1990
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
- 9255 Towne Centre Drive
- Suite 350
- San Diego, CA 92121
- United States
+1 (858) 000-0000
Forward Ventures Investments & Acquisitions (100)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Virtuoso | 09-Nov-2021 | Later Stage VC | 000.00 | Software Development Applications | Generating Revenue | |
00 000 000000 | 04-Oct-2021 | 00000 00000 | 000 | Media and Information Services (B2B) | Generating Revenue | |
00000000000 | 14-Jun-2021 | 00000 00000 | 000.00 | Industrial Chemicals | Generating Revenue | |
00000000 | 20-Aug-2019 | 00000 00000 | 00.000 | Software Development Applications | Generating Revenue | |
0000000 | 12-Feb-2019 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 0000 0000000 00 |
0000000 | 04-Apr-2017 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 0000 0000000 00 |
000000 | 24-Aug-2015 | 00000 00000 | 0000 | Drug Discovery | Profitable | 0000 0000000 00 |
00000000 000000000 | 30-Aug-2013 | 00000 00000 | 000.00 | Pharmaceuticals | Out of Business | 000000 000000000 00.0 |
Syndax | 29-Aug-2013 | Later Stage VC | 000.00 | Drug Discovery | Profitable | 0000 0000000 00 |
Ambit Biosciences | 15-May-2013 | IPO | 0000 | Pharmaceuticals | Clinical Trials - Phase 3 | 00000000 0000000 |
Forward Ventures Exits (55)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Viracta | 24-Feb-2021 | Reverse Merger | |
0000000 | 01-Feb-2021 | 000000000 00000000 | |
0000000 0000000000 | 01-Feb-2021 | 000000000 00000000 | |
0000000 | 15-May-2019 | 0000000000: 000000 | |
000000 0000000 | 01-Jan-2018 | 0000000000: 000000 | |
00000000000 | 07-Mar-2017 | 000000000000000000 | 000.00 |
000000 | 03-Mar-2016 | 000 | 000.00 |
000000000 | 01-Aug-2014 | 0000000000: 000000 | |
Affinium Pharmaceuticals | 11-Feb-2014 | Merger/Acquisition | |
Affinium Pharmaceuticals (Clinical and Preclinical Assets and Ceratin Assets) | 11-Feb-2014 | Merger/Acquisition |
Forward Ventures Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Forward Ventures Investments by Industry, Year, and Region
Forward Ventures Team (10)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Caroline Barberio | Chief Financial Officer | San Diego, CA | |||
Standish Fleming | Founding Managing Partner | 00 | 0 | 0 | San Diego, CA |
Stuart Collinson Ph.D | Partner | 00 | 0 | 0 | San Diego, CA |
Forward Ventures Co-Investors (25)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Forward VC | 2 |
![]() |
![]() |
||
Latterell Venture Partners | 0 | 0 | 0 |
![]() |
![]() |
NantKwest | 0 | 0 | 0 |
![]() |
![]() |
Paladin Capital Group | 0 | 0 |
![]() |
![]() |
|
Skandinaviska Enskilda Banken | 0 |
![]() |
![]() |